InvestorsHub Logo
Followers 10
Posts 673
Boards Moderated 0
Alias Born 01/19/2014

Re: kayak_wench post# 115077

Sunday, 07/06/2014 4:49:51 PM

Sunday, July 06, 2014 4:49:51 PM

Post# of 401067
I think he understands that once these first 3 drugs are approved than the rest of the pipeline is change in dosage. The risk goes down substantially and the valuation becomes much higher. Elite can use that 500k to upgrade manufacturing facilities but would still only support the first maybe the second drug. They will need a partner or buyout with additional drugs and the sweet spot for shareholders would be after approval of 1-2 ART drugs but before demand and additional trials begin. This may be a tight timeframe but IMO he has already laid the ground work for this scenario.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News